Feed Preview

Prion Disease

Prion Disease diagram by StudioMolekuul, Shutterstock
StudioMolekuul, Shutterstock

Prion diseases or transmissible spongiform encephalopathies are rare progressive neurogenerative diseases caused by misfolded prion proteins. Here is the latest research in this domain.

Top 20 most recent papers
May 22, 2020

Refractory status epilepticus in genetic Creutzfeldt-Jakob disease with E200K mutation

Neurología : publicación oficial de la Sociedad Española de Neurología
A Gómez RoldósJ R Pérez Sánchez
April 29, 2020
Open Access

Long-Term Incubation PrPCWD with Soils Affects Prion Recovery but Not Infectivity

Pathogens
Alsu KuznetsovaJudd M Aiken
May 7, 2020

The dual role of c-src in cell-to-cell transmission of α-synuclein

EMBO Reports
Yu Ree ChoiSang Myun Park
May 21, 2020

18F-FDG PET/CT in Sporadic Creutzfeldt-Jakob Disease

Clinical Nuclear Medicine
Ghali ZiziDavid Morland
April 29, 2020

Pachymeter Use and Disinfection Practice in the United Kingdom (UK): A National Survey

Journal of Glaucoma
Kirti M JasaniArchana Bhargava
May 23, 2020
Review

Evidence of distinct α-synuclein strains underlying disease heterogeneity

Acta Neuropathologica
Sara A M Holec, Amanda L Woerman
May 5, 2020

The Braak hypothesis in prion disease with a focus on Creutzfeldt-Jakob disease

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Yasushi Iwasaki
May 21, 2020
Case ReportOpen Access

Functional Magnetic Resonance Imaging in the Final Stage of Creutzfeldt-Jakob Disease

Diagnostics
Stefan M GolaszewskiEugen Trinka
May 7, 2020

Tracking the physical stability of fluorescent-labeled mAbs under physiologic invitro conditions in human serum and PBS

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Joachim SchusterRoman Mathaes
May 12, 2020

Proteomics in Neurodegenerative Disease

Current Protein & Peptide Science
Nidhi PuranikJun-O Jin

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/prion-disease/7713743f-02e5-4a7b-8a23-0d1a5a0bb624